Volume 32 contains issues of interest to scientists working in pharmacology, biochemistry, and physiology, particularly to those in HIV, cancer, neurology, and cardio-vascular research and medicine. The chapters on new approaches to cancer therapy and schizophrenia will be of special interest to pharmacologists. Each volume of Advances in Pharmacology provides a rich collection of reviews on timely topics. Emphasis is placed on the molecular bases of drug action, both applied and experimental.
Pharmacologists, immunologists, and neuroscientists at the research level.
- No. of pages:
- © Academic Press 1995
- 14th February 1995
- Academic Press
- eBook ISBN:
- Hardcover ISBN:
@from:Praise for the Serial @qu:"The book provides superb reading material which chemists and pharmacologists...will surely enjoy reading." @source:--JOURNAL OF PHARMACEUTICAL SCIENCES
John Hopkins University; Department of Pharmacology, Baltimore, Maryland, U.S.A.
University of Rochester; Department of Pharmacology, New York, U.S.A.
Ferid Murad was born in Whiting, Indiana. Working concurrently on an M.D. and Ph.D. in Pharmacology, Dr. Murad graduated with both degrees from Case Western Reserve University, Cleveland, Ohio, in 1965. His many honors include the Alfred S. Maschke Award for Clinical Excellence from Case Western Reserve University in 1965. He has held several distinguished positions, including Acting Chairman in the Department of Medicine and Acting Division Chief, Division of Respiratory Medicine at Stanford University. He currently is CEO and President of Molecular Geriatrics Corporation in Lake Bluff, Illinois. Dr. Murad is married and has five children.
University of Texas Medical School, Houston, U.S.A.
McLean Hospital, Harvard Medical School, Belmont, Massachusetts, U.S.A.